Brief: Rhythm Biosciences Ltd Confirms Director Share Sale To Institutional Funds Manager
09/09/2022 02:36
Sept 9 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* CONFIRMS AN EXCLUSIVE SHARE SALE CONDUCTED BY EXECUTIVE
CHAIRMAN
TO A SINGLE DOMESTIC FUND MANAGER
* SALE OF 5 MILLION RHY SHARES AT A$1.30 PER SHARE BY
EXECUTIVE
CHAIRMAN
* RHYTHM BIOSCIENCES LTD -NO FURTHER SHARE SALES ENVISAGED
FOR
FORESEEABLE FUTURE
Source text for Eikon: ID:nASX6LrkSW
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt